ABLIVA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1648 SEK | +1.10% |
|
+3.26% | -32.87% |
| Feb. 23 | Abliva AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
| 2023 | Abliva AB Reaches Patient Enrollment Goal for Wave 1 of the FALCON Study | CI |
Quotes 5-day view
Delayed Quote Nasdaq Stockholm| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|
| Last | 0.169 kr | 0.16 kr | 0.163 kr | 0.1648 kr |
| Volume | 1 307 990 | 1 582 808 | 932 598 | 662 886 |
| Change | +1.93% | -5.33% | +1.88% | +1.10% |
| Opening | 0.17 | 0.17 | 0.16 | 0.16 |
| High | 0.17 | 0.17 | 0.16 | 0.17 |
| Low | 0.16 | 0.16 | 0.16 | 0.16 |
Performance
| 1 day | +1.10% | ||
| 1 week | +3.26% | ||
| Current month | +1.60% | ||
| 1 month | +1.60% | ||
| 3 months | -31.19% | ||
| 6 months | -26.76% | ||
| Current year | -32.87% | ||
| 1 year | -28.97% | ||
| 3 years | -77.86% | ||
| 5 years | -87.26% | ||
| 10 years | -99.27% |
Volumes
marketsDaily volume
662 886
Estimated daily volume
662 886
Avg. Volume 20 sessions
1 325 316
Daily volume ratio
0.50
Avg. Volume 20 sessions SEK
218 412.08
Avg. Volume 20 sessions USD
20 055.25
Record volume 1
125 182 700
Record volume 2
93 268 770
Record volume 3
69 771 890
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (SEK)
220 885 138
Capitalization (USD)
20 282 336
Net sales (SEK)
0
Net sales (USD)
0
Number of employees
8
Sales / Employee (SEK)
0
Sales / Employee (USD)
0
Free-Float
88.06 %
Free-Float capitalization (SEK)
152 269 548
Free-Float capitalization (USD)
13 981 847
Average Daily Capital Traded
0.1%
Highs and lows
1 week
0.16
0.17
1 month
0.140.18
Current year
0.140.27
1 year
0.140.32
3 years
0.140.79
5 years
0.142.68
10 years
0.1482.00
Indicators
Moving average 5 days
0.16
Moving average 20 days
0.16
Moving average 50 days
0.17
Moving average 100 days
0.21
Price spread / (MMA5)
-0.18%
Price spread / (MMA20)
-3.03%
Price spread / (MMA50)
+3.09%
Price spread / (MMA100)
+25.42%
STIM
RSI 9 days
52.80
RSI 14 days
50.01
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.10% | +3.26% | -32.87% | -28.97% | 20.28M | ||
| -0.06% | +0.81% | -2.31% | +16.66% | 103B | ||
| -0.84% | -1.52% | +0.56% | +10.15% | 95.28B | ||
| +0.90% | +3.56% | +1.69% | +0.17% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -23.66% | 21.02B | ||
| +2.04% | -2.57% | -9.30% | -29.69% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -36.44% | 16.73B | ||
| +3.38% | +18.58% | -14.85% | -39.76% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +34.59% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +4.89% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -34.07% | 8.24B | ||
| +7.91% | +17.17% | +299.30% | +248.71% | 8.19B | ||
| -0.75% | -3.05% | +7.90% | +94.25% | 7.76B | ||
| +0.95% | +0.62% | +0.17% | +46.25% | 7.71B | ||
| +5.49% | +11.56% | -51.76% | -69.29% | 7.17B | ||
| +0.72% | +5.24% | -1.21% | +29.51% | 6.99B | ||
| Average | +1.68% | +3.99% | +9.44% | +13.96% | ||
| Weighted average by Cap. | +0.59% | +1.87% | +2.14% | +9.57% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
df44f9d8425.Cq9qlUJYhDutWmVxcpKIsvaTCqSTwjpiWpL7BcUgQLc.TOcA3is5tnOYMVcgJePa_Iz9TJf3nW4kKcaTKK1td-NAmi3mNXXMWcA-NA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 11:29:55 am | 0.1648 | 1,814 | 662,886 |
| 11:29:55 am | 0.1648 | 206 | 661,072 |
| 11:29:55 am | 0.1648 | 41 | 660,866 |
| 11:21:39 am | 0.1616 | 12,000 | 660,825 |
| 11:20:33 am | 0.1648 | 135 | 648,825 |
| 11:14:33 am | 0.1616 | 3,000 | 648,690 |
| 11:07:24 am | 0.1616 | 39,281 | 645,690 |
| 11:02:40 am | 0.1606 | 3,363 | 606,409 |
| 11:01:20 am | 0.1612 | 80 | 603,046 |
| 11:00:32 am | 0.1648 | 606 | 602,966 |
Monthly variations
Annual change
| 2024 | -32.87% | ||
| 2023 | +37.15% | ||
| 2022 | -70.04% | ||
| 2021 | -21.90% | ||
| 2020 | -42.91% | ||
| 2019 | -2.90% | ||
| 2018 | -53.69% | ||
| 2017 | -10.51% | ||
| 2016 | -65.31% | ||
| 2015 | -81.18% | ||
| 2014 | +177.17% | ||
| 2013 | +2.22% | ||
| 2012 | +42.86% | ||
| 2011 | -55.32% | ||
| 2010 | +158.72% | ||
| 2009 | +98.18% | ||
| 2008 | -15.38% |
- Stock Market
- Equities
- ABLI Stock
- Quotes Abliva AB
